INT156109

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.40
First Reported 2008
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 6
Total Number 6
Disease Relevance 0.92
Pain Relevance 0.41

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Anatomy Link Frequency
arm 1
pituitary 1
TSS (Mus musculus)
Pain Link Frequency Relevance Heat
methotrexate 25 98.82 Very High Very High Very High
Etanercept 25 95.88 Very High Very High Very High
visual analogue scale 2 78.00 Quite High
headache 19 77.84 Quite High
Pain 2 75.92 Quite High
rheumatoid arthritis 6 55.28 Quite High
Migraine 2 23.64 Low Low
abdominal pain 2 14.52 Low Low
cytokine 14 5.00 Very Low Very Low Very Low
pruritus 6 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Headache Disorders 2 96.52 Very High Very High Very High
Sneezing 8 83.40 Quite High
Cough 10 82.84 Quite High
Pharyngitis 8 81.52 Quite High
Sleep Disorders 6 79.44 Quite High
Headache 15 77.84 Quite High
Pain 1 75.92 Quite High
Infection 4 74.08 Quite High
Common Cold 31 61.92 Quite High
Rheumatoid Arthritis 6 55.28 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The authors identified 41 patients with small pituitary tumors who underwent TSS, and retrospectively evaluated the resolution and/or treatment of headache.
Positive_regulation (underwent) of TSS in pituitary
1) Confidence 0.40 Published 2009 Journal J. Neurosurg. Section Body Doc Link 19012490 Disease Relevance 0.09 Pain Relevance 0
METHODS: The authors conducted a retrospective review of 512 patients who underwent TSS at Oregon Health & Science University between 2001 and 2007; patients with Cushing disease were excluded.
Positive_regulation (underwent) of TSS
2) Confidence 0.40 Published 2009 Journal J. Neurosurg. Section Body Doc Link 19012490 Disease Relevance 0.10 Pain Relevance 0
Total Symptom Score (TSS) was calculated for the patients of both groups on their first and second visits.
Positive_regulation (calculated) of TSS
3) Confidence 0.04 Published 2010 Journal Indian Journal of Pharmacology Section Body Doc Link PMC2885633 Disease Relevance 0 Pain Relevance 0
The trendline in the scatter diagram [Figure 1] shows an increase in AEC with an increase in TSS.


Positive_regulation (increase) of TSS
4) Confidence 0.03 Published 2010 Journal Indian Journal of Pharmacology Section Body Doc Link PMC2885633 Disease Relevance 0.22 Pain Relevance 0.08
In the methotrexate arm, however, the 24-week responders showed a significant increase in TSS at 52 weeks compared with the 12-week responders.


Positive_regulation (increase) of TSS in arm associated with methotrexate
5) Confidence 0.02 Published 2008 Journal Annals of the Rheumatic Diseases Section Body Doc Link PMC2566536 Disease Relevance 0.13 Pain Relevance 0.34
Both the Iota-Carrageenan and the placebo group reached a mean TSS level of around 2 at the end of the 7 day observation period (Figure 2).
Positive_regulation (reached) of TSS
6) Confidence 0.02 Published 2010 Journal Respir Res Section Body Doc Link PMC2923116 Disease Relevance 0.38 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox